NON-HODGKIN-LYMPHOMACLINICAL-FEATURESADOLESCENTSCHILDHOODTRIALA5971The purpose of the study was to review the clinical and pathologic characteristics and treatment results of children with precursor B-cell lymphoblastic lymphoma. Of 530 children diagnosed with non-Hodgkin lymphomas between 2000 and 2021, ...
precursor B-cell Lymphoblastic lymphomaPrecursor B-cell lymphoblastic lymphoma (PB-LBL) is a rare and aggressive sub-type of non-Hodgkin lymphoma (NHL) that rarely manifests in the orbit, and is exceedingly rare in adults. Here, we report on a 21-year old man who presented with ocular ...
Pre-B-cell non-Hodgkin's lymphoma in childhood. Report of a case and review of the literature. The authors studied a six-year-old girl with a cervical lymphoblastic lymphoma. Initial blood study results were within normal ranges, and no evidence of l... WA Kamps,S Poppema - 《American ...
Precursor T-cell lymphoblastic leukemias and lymphomas represent 15% of childhood acute lymphoblastic leukemias (ALLs) and one third of pediatric non-Hodgkin lymphomas, respectively. T-cell ALLs are cDOI: 10.1007/978-1-4419-5698-9_26 被引量: 1 年份...
t(14;18)-frequency was highest in IgM memory cells, a B-cell subset that shares immunophenotypic similarities with FL. The significance of these cells as lymphoma precursors or indicators of lymphoma risk remains to be established. 展开
B-cell malignancies, such as the B-cell subtype of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, are significant contributors to cancer mortality. The response of B-cell malignancies to various forms of treatment is mixed. Tra... DM Goldenberg - US 被引量: 495发表: 1998年 Immunoth...
We excluded specimens from 5 who had received a diagnosis of myeloma or non-Hodgkin lymphoma prior to blood sampling. We also excluded participants younger than 50 or older than 79 years at the time of blood sampling. The final study cohort included 781 white, male, WTC-exposed firefighters ...
The malignant causes are first hematological as acute lymphoblastic leukemia (ALL)[3,8], acute myelogenous leukemia, chronic myelogenous leukemia, myeloma, Hodgkin’s disease[3,18], non-Hodgkin’s lymphoma (NHL)[19,20] and high-grade B-cell lymphoproliferative disease (central nervous system invol...
Several preclinical studies showed that very low concentrations of blinatumomab mediate redirected lysis of human B lymphoma and leukemia cells. A phase I study has demonstrated significant clinical activity of the BiTE antibody in relapsed B-cell non-Hodgkin's lymphoma (NHL). Based on these results...
NPM-ALK is a fusion protein created by translocation between NPM (B23) and ALK and thought to be the causative oncogene in many anaplastic large-cell lymphomas (ALCL). ALCL comprises a group of non-Hodgkin’s lymphomas, approximately half of which are associated with NPM-ALK translocation (...